[1] 高岩,邱艳.血液质量管理的有效工具Haemovigilance[J].中国输血杂志,2015,28(9):1154-1158. [2] 邱艳. Haemovigilance的发展现状及思考[J].北京医学,2009,31(2):111-113. [3] WHO.User guide for navigating resources on stepwise implementation of haemovigilance systems[EB/OL].[2022-11-17].https://www.who.int/publications/i/item/9789240047860. [4] 中国输血协会.血液安全监测指南[S].2019. [5] POLITIS C,WIERSUM J C,RICHARDSON C,et al.The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components:technical issues and results[J]. Vox Sang,2016,111(4):409-417. [6] POLITIS C,WIERSUM-OSSELTON J,RICHARDSON C,et al.Adverse reactions following transfusion of blood components,with a focus on some rare reactions:reports to the International Haemovigilance Network Database (ISTARE) in 2012-2016[J]. Transfus Clin Biol,2022,29(3):243-249. [7] ALMUTAIRI H,SALAM M,ALAJLAN A,et al.Incidence,predictors and severity of adverse events among whole blood donors[J]. PLoS One,2017,12(7):e0179831. [8] SAHU S,Hemlata,VERMA A.Adverse events related to blood transfusion[J]. Indian J Anaesth,2014,58(5):543-551. [9] JHAVERI P,BOZKURT S,MOYAL A,et al.Analyzing real world data of blood transfusion adverse events:opportunities and challenges[J]. Transfusion,2022,62(5):1019-1026. [10] 万建华,袁晓华,周吉霞. 采供血环节差错原因分析及预防对策[J]. 新疆医学,2017,47(2):182-183. [11] 袁海涛. 2015—2019年血站质量管理不合格项回顾性分析[J].江苏卫生事业管理,2021,32(6):775-778. [12] 贾桂丛,陈莉,安翠平,等.某省血液安全事件分类规范研究[J]. 中国卫生质量管理,2018,25(6):8-11. [13] THE ROYAL COLLEGE OF PATHOLOGISTS.ANNUAL SHOT REPORT2021 [EB/OL].[2022-11-17].https://www.shotuk.org/wp-content/uploads/myimages/SHOT-REPORT-2021-FINAL-bookmarked-V2-September.pdf. [14] 贾璐,石洁,郑建勇.血站质量管理体系不合格项回顾性分析[J].中国卫生质量管理,2019,26(6):119-121. [15] 张春梅. 临沂市中心血站质量管理体系不合格项的统计分析[J].中国输血杂志,2019,32(3):307-309. [16] 李小红,黄霞,谢东甫,等. 采供血不良事件监测模式探索—《血液安全监测指南》团标修订之解析[J]. 中国输血杂志,2019,32(10):1063-1065. |